title: Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
authors.forename: Britta
authors.initials: B
authors.lastname: H-Stenstam
mesh_terms: D000328:Adult; D000368:Aged; D001895:Boron / Q000097:blood; D001896:Boron Compounds / Q000008:administration & dosage* / Q000493:pharmacokinetics; D016754:Boron Neutron Capture Therapy / Q000009:adverse effects / Q000379:methods*; D001932:Brain Neoplasms / Q000532:radiotherapy*; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D005632:Fructose / Q000008:administration & dosage / Q000493:pharmacokinetics; D005909:Glioblastoma / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010649:Phenylalanine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011788:Quality of Life; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D001896:Boron Compounds; D005632:Fructose; D010649:Phenylalanine; D001895:Boron